LungArchives
Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer
Lung 1 min.
Although tyrosine kinase inhibitors (TKIs) significantly improve survival outcomes in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), tumor clonal evolution under drug pressure inevitably leads to acquired resistance. DNA damage response (DDR) mutations...
Integration of blood protein-metabolic profiles via machine learning to enable the accurate early detection of non-small cell lung cancer
Lung 1 min.
Non-small cell lung cancer (NSCLC) poses a major threat to human health due to its high morbidity and mortality. Early accurate diagnosis and differential diagnosis from other respiratory diseases, are pivotal to improving patient prognosis. This study aimed to construct an NSCLC diagnostic model based...
Salvage surgery in non-small cell lung cancer: a three-decade bibliometric and clinical appraisal of the most influential studies
Lung 1 min.
This study aims to provide a comprehensive bibliometric evaluation of the most influential publications on salvage surgery for non-small cell lung cancer from 1991 to 2023, highlighting scientific trends, geographic contributions, journal impact, and major clinical themes. A systematic search was conducted...
Artificial intelligence-assisted risk prediction of postoperative pulmonary complications in non-small cell lung cancer surgery
Lung 1 min.
Pulmonary complications are the most frequent adverse events following surgery for non-small cell lung cancer (NSCLC), influencing both short-term clinical outcomes and long-term prognosis. This study aimed to develop and evaluate artificial intelligence (AI) models to predict postoperative pulmonary...
